Health Care & Life Sciences » Pharmaceuticals | Synthetic Biologics Inc.

Synthetic Biologics Inc.

Synthetic Biologics Inc.
Stock Exchange NYSE
EPS
$3.45
Market Cap
$9.24 M
Shares Outstanding
16.48 M
Public Float
12.68 M

Profile

Address
9605 Medical Center Drive
Rockville Maryland 20850
United States
Employees -
Website http://www.syntheticbiologics.com
Updated 07/08/2019
Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004. The SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation.

Financials

View All

Jeffrey J. Kraws
Independent Non-Executive Chairman
Jeff A. Wolf
Independent Director